New York, NY · Founded 2012 · Privately Held (backing)
Developer of hemostatic products designed to support the natural clotting and promote wound healing. Cresilon is based in New York, NY and was founded in 2012. Its last reported valuation was $340 million in Apr 2024. It has raised $160 million across 8 recorded rounds; the latest was a $29 million early-stage round in Apr 2026.
Last reported valuation
$340.0M
Oct 2026
Priced at
—
Total raised
$159.5M
Last round
Early Stage VC
Apr 2026
Team — not yet on record
No current team members for Cresilon are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cresilon with a free account
·The complete investor list: 20 names
·Watch Cresilon: the Monday email on marks, rounds and moves
